SCHEMBL17486571

SCHEMBL17486571

NCCCNCc1ccc(-c2c[nH]c(NC(=O)Nc3ccccc3OCF)nc2=O)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 13/20 0.38
ROCK2 O75116 1/20 0.34
LIMK1 P53667 1/20 0.34
IL6 P05231 2/20 0.33
TLR7 Q9NYK1 2/20 0.33
KMT2A Q03164 2/20 0.33
HTR3E A5X5Y0 1/20 0.33
HTR3B O95264 1/20 0.33
HTR3A P46098 1/20 0.33
HTR3D Q70Z44 1/20 0.33
HTR3C Q8WXA8 1/20 0.33
MEN1 O00255 1/20 0.33
PABPC1 P11940 1/20 0.33
IKBKB O14920 1/20 0.32
CHUK O15111 1/20 0.32
LYN P07948 1/20 0.32
SYK P43405 1/20 0.32
MAPK8 P45983 1/20 0.32
MAPK10 P53779 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17354506 0.91 IGF1R (0.38) IGF1RROCK2LIMK1KMT2AMEN1
SCHEMBL14850252 0.91 KDR (0.39) IGF1RIKBKBCHUKLYNSYK
SCHEMBL17354473 0.88 IGF1R (0.37) IGF1RROCK2LIMK1
SCHEMBL17354348 0.88 KDR (0.37) IGF1RROCK2LIMK1IL6TLR7
SCHEMBL17354480 0.88 IGF1R (0.36) IGF1RROCK2LIMK1KMT2AMEN1
SCHEMBL17486573 0.86 IGF1R (0.35) IGF1RKMT2AMEN1MAPT
SCHEMBL14383 0.85 IGF1R (0.36) IGF1RROCK2LIMK1IKBKBCHUK
SCHEMBL14140 0.85 IGF1R (0.34) IGF1RIL6TLR7KMT2AMEN1
SCHEMBL17354235 0.85 LIMK1 (0.34) IGF1RROCK2LIMK1IL6TLR7
SCHEMBL17486587 0.84 IGF1R (0.36) IGF1RROCK2LIMK1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160031828-A1 ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME SILICON VALLEY BANK 2016-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160031828-A1 ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME MPO, LPO, CAT IGF1R 4795/4885ROCK2 3307/4885LIMK1 3838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.